Previous 10 | Next 10 |
2024-02-15 18:54:02 ET Bio-Rad Laboratories, Inc. (BIO) Q4 2023 Earnings Conference Call February 15, 2024, 5:00 PM ET Company Participants Edward Chung - Head, Investor Relations Norman Schwartz - Chief Executive Officer Andy Last - Executive Vice President and ...
2024-02-15 16:43:22 ET More on Bio-Rad Labs Bio-Rad Labs Q4 2023 Earnings Preview Danaher, Repligen rise as German peer Sartorius beats in Q4 Seeking Alpha’s Quant Rating on Bio-Rad Labs Historical earnings data for Bio-Rad Labs Financial infor...
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced financial results for the fourth quarter and full year ended December 31, 2023. Fourth-quarter 2023 total net sales were $681.2 million, a decrease of ...
Propanc Biopharma Inc (PPCB) is expected to report for Q2 2024 Bank of Georgia Group Plc (BDGSF) is expected to report for quarter end 2023-12-31 Arch Resources Inc. Class A (ARCH) is expected to report $6.9 for Q4 2023 Bloom Energy Corporation Class A (BE) is expected to report $-0.0...
2024-02-07 19:28:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-02-07 13:43:49 ET More on S&P 500 Index: A Technical View Of Potential Downside For The Market Sterling Moves Back Into Previous Trading Range, But Will It Hold? The Warning Signs In The Stock Market Are Clear And Present (Technical Analysis) Stocks ...
2024-01-31 06:05:00 ET Summary Longleaf Partners Funds is a suite of mutual funds and UCITS funds that Southeastern Asset Management, the investment advisor to the Longleaf Partners Funds, created in 1987 as a way for Southeastern employees to invest alongside their clients. 2023 ...
2024-01-26 12:23:42 ET More on Bio-Rad Labs, Danaher, etc. Thermo Fisher: Blue Chip Stock Melded With Growth Characteristics J.P. Morgan 42nd Annual Healthcare Conference Danaher Corporation (DHR) 42nd Annual JPMorgan Healthcare Conference (Transcript) Thermo...
2024-01-25 11:31:54 ET More on S&P 500 Index: The Most Important New All-Time High Has Yet To Be Achieved Fed Preview: Expect Interest Rate Cuts In May, June, November And December Attention Turns To Lagarde's Press Conference And U.S. Q4 GDP These are th...
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostics products, will report its financial results for the fourth quarter and full year 2023 on Thursday, February 15, 2024, following the close of the market. Management will discuss these...
News, Short Squeeze, Breakout and More Instantly...
Bio-Rad Laboratories Inc. Class A Company Name:
BIO Stock Symbol:
NYSE Market:
2024-05-09 12:34:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced financial results for the first quarter ended March 31, 2024. First-quarter 2024 total net sales were $610.8 million, a decrease of 9.8 percent compare...
Aterian Inc. (ATER) is expected to report for Q1 2024 Dorman Products Inc. (DORM) is expected to report $0.82 for Q1 2024 Hillman Solutions Corp. (HLMN) is expected to report $0.08 for Q1 2024 Wake Forest Bancshares, Inc. (WAKE) is expected to report for quarter end 2024-03-31 Inn...